BioWorld MedTech

Sep. 19, 2012

Aptus snags FDA 510(k) for thoracic-length HeliFX

Aptus Endosystems (Sunnyvale, California), a device company developing technology for endovascular aneurysm repair (EVAR), said it has received FDA 510(k) clearance for its thoracic-length HeliFX Aortic Securement System. Read More

Neovasc upbeat about Tiara preclinical study results

International report: Medical Care Technologies signs MOU with Dragon Link

Washington roundup: MHRA wants more frequent follow-up of St. Jude's Riatas

Financings roundup: Health Care REIT in plan to offer up to 22 million shares

Agreements/contracts: Illumina to provide MiSeq to FDA for genome analysis

HIT roundup: Consumers are beginning to comparison shop healthcare

Med-Tech Notes

People in the News

Product Briefs

FDA approves somo-v ABUS system for dense breast tissue

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...